​

Funding Round

Venture Round - Genezen

Venture Round - Genezen

Investment Firm

Overview

Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services.

Announced Date

Nov 02, 2023

Closed on Date

Nov 02, 2023

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Ampersand Capital Partners

Ampersand Capital Partners

Ampersand Capital Partners is a debt and early_stage_venture and late_stage_venture and private_equity and seed and venture firm.

Participant Investors

1

Investor Name
Participant InvestorAmpersand Capital Partners

Round Details and Background

Genezen raised $18500000 on 2023-11-02 in Venture Round

Genezen offers contract process development, GMP viral vector production, transduced cell manufacturing, and testing services.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 02, 2023
Venture Round - Genezen
1-18.5M

Recent Activity

There is no recent news or activity for this profile.